FDA Drug Recalls

Recalls / Class II

Class IID-0608-2018

Product

Evamist (estradiol transdermal spray), 1.53mg estradiol/spray, 0.27 fl oz (8.1 mL) per bottle, Rx Only, Manufactured for Perrigo, Minneapolis, MN 55427. NDC: 0574-2067-27

Brand name
Evamist
Generic name
Estradiol
Active ingredient
Estradiol
Route
Transdermal
NDC
0574-2067
FDA application
NDA022014
Affected lot / code info
Lot: MEEF Exp. 04/2020

Why it was recalled

Defective Delivery System: Potential that cracks in the vial neck near the crimp may result in product evaporation and/or leaking and the inability to properly dispense product.

Recalling firm

Firm
Paddock Laboratories, LLC.
Manufacturer
Padagis US LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
3940 Quebec Ave N, New Hope, Minnesota 55427-1244

Distribution

Quantity
52,596 bottles
Distribution pattern
Nationwide within the USA.

Timeline

Recall initiated
2018-02-26
FDA classified
2018-03-28
Posted by FDA
2018-04-04
Terminated
2020-07-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0608-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Evamist · FDA Drug Recalls